Our study demonstrated that KIAA1429 might facilitate DLBCL progression by inhibiting CHST11 expression and attenuating the activation of Hippo–YAP signaling caused by the interaction of CHST11 with MOB1B. The gene discussed is CHST11; the disease is diffuse large B-cell lymphoma.